Consort Medical PLC Director/PDMR Shareholding (7295Y)

TIDMCSRT

RNS Number : 7295Y

Consort Medical PLC

10 September 2015

Consort Medical plc

Notification of Transactions of Directors or

Persons Discharging Managerial Responsibility and Connected Persons

DTR 3.1.4

On 10 September 2015, following the approval by shareholders of the Consort Medical plc Performance Share Plan 2015 ('PSP') at the Annual General Meeting held on 3 September 2015 and pursuant to the terms of the PSP, the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares in the Company ("Shares").

 
 Director/PDMR     Number of Shares 
 Jonathan Glenn         49,308 
                  ----------------- 
 Richard Cotton         32,043 
                  -----------------

Each of the awards was granted as a nil cost option, in replacement for, in respect of the same number of Shares and subject to the same vesting period and performance targets as the awards granted to the Directors on 19 June 2015 under the 2005 Long Term Incentive Plan ('LTIP') which awards have now lapsed following the grant of the new awards under the PSP.

   Enquiries:      I Ward             01442 867920

Consort Medical plc is a leading, global, single source drug and delivery device CDMO through its two operating subsidiaries Bespak and Aesica. Consort Medical is at the leading edge of innovation and is committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners.

The Group has facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Nottingham, Queenborough and Hemel Hempstead, UK; in Monheim and Zwickau, Germany; and in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). The Group's website address is www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZBLFFEKFFBBB

(END) Dow Jones Newswires

September 10, 2015 10:11 ET (14:11 GMT)

Bespak (LSE:BPK)
Historical Stock Chart
From Apr 2024 to May 2024